Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
39.47
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Kobayashi Pharmaceutical Net Income (Quarterly) : 0.6338M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6338M |
| March 31, 2026 | 6.609M |
| December 31, 2025 | -20.44M |
| September 30, 2025 | 24.73M |
| June 30, 2025 | 10.65M |
| March 31, 2025 | 10.65M |
| December 31, 2024 | 31.01M |
| September 30, 2024 | 26.20M |
| June 30, 2024 | 2.952M |
| March 31, 2024 | 6.573M |
| December 31, 2023 | 32.71M |
| September 30, 2023 | 52.81M |
| June 30, 2023 | 30.96M |
| March 31, 2023 | 27.25M |
| December 31, 2022 | 39.05M |
| September 30, 2022 | 49.16M |
| June 30, 2022 | 32.56M |
| March 31, 2022 | 29.86M |
| December 31, 2021 | 42.49M |
| September 30, 2021 | 63.61M |
| June 30, 2021 | 38.88M |
| March 31, 2021 | 34.19M |
| December 31, 2020 | 37.78M |
| September 30, 2020 | 66.33M |
| June 30, 2020 | 41.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 34.34M |
| December 31, 2019 | 35.82M |
| September 30, 2019 | 65.62M |
| June 30, 2019 | 41.10M |
| March 31, 2019 | 33.44M |
| December 31, 2018 | 37.74M |
| September 30, 2018 | 57.23M |
| June 30, 2018 | 34.88M |
| March 31, 2018 | 35.28M |
| December 31, 2017 | 36.52M |
| September 30, 2017 | 42.38M |
| June 30, 2017 | 32.23M |
| March 31, 2017 | 30.42M |
| December 31, 2016 | 56.40M |
| September 30, 2016 | 28.14M |
| June 30, 2016 | 48.20M |
| March 31, 2016 | 40.39M |
| March 31, 2015 | 14.90M |
| December 31, 2014 | 45.59M |
| September 30, 2014 | 29.21M |
| June 30, 2014 | 23.67M |
| March 31, 2014 | 20.03M |
| December 31, 2013 | 42.80M |
| September 30, 2013 | 30.22M |
| June 30, 2013 | 30.02M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Medifast, Inc. | -3.10M |
| Integrated BioPharma, Inc. | -1.366M |
| Kao Corp. | 219.14M |
| Shiseido Co., Ltd. | 129.66M |
| Skinvisible, Inc. | -0.2555M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 232.72M |
| Total Expenses (Quarterly) | 232.08M |
| EPS Diluted (Quarterly) | 0.0084 |
| Enterprise Value | 2.586B |
| Gross Profit Margin (Quarterly) | 49.95% |
| Profit Margin (Quarterly) | 0.27% |
| Earnings Yield | 0.39% |
| Operating Earnings Yield | 2.35% |
| Normalized Earnings Yield | 2.942 |